Opinion channel feed – Endpoints News

Opinion channel feed

AstraZeneca CEO Pascal Soriot severs an unusual board connection, steering clear of conflicts while retaining important alliances

5 years ago

Scoop: Vivek Ramaswamy is handing the CEO job to a top lieutenant at Roivant — but he’s not exactly leaving the biotech scene

5 years ago

Pssst: That big Biohaven Alzheimer's study? It was a bust. Even the subgroup analysis execs touted was a flop

5 years ago

The final hours and days are ticking away on a $6B bet as deadline looms on a suspenseful FDA decision

5 years ago

It's a big day for Moderna — and the world — as the FDA stamps an EUA on their vaccine. And there are some important lessons to remember

5 years ago

John Connolly has a new mission to tack on to his role at the Parker Institute: interim chief of a buzzy biotech backed by a pair of billionaires

5 years ago

CRISPR upstart ticks off another box on the IPO prep list as RA, SVB Leerink step in on a mega-raise

5 years ago

Carl Hansen is just about ready to grab the key to the exclusive Covillionaire club

5 years ago

Capping Pascal Soriot’s big turnaround, the analysts at Cowen say AstraZeneca is poised for a stellar year

5 years ago

Overnight fortunes are being made in biotech these days — and it's both encouraging and more than a little bit scary

5 years ago

The aducanumab conundrum: The PhIII failed a clear regulatory standard, but no one is certain what that means anymore at the FDA

5 years ago

The FDA's insider review on aducanumab was all about politics, not science, and it threatens patients and the biopharma industry alike

5 years ago

Sean Bohen just wrote the handbook on how to make a quick fortune in biotech

5 years ago

What are the right ingredients for a blockbuster unicorn IPO? Norbert Bischofberger has some thoughts on that

5 years ago

Amgen posts upbeat assessment of PhII KRAS data on AMG510 — but there's no clear picture of what researchers saw

5 years ago

Alone in the spotlight, Pfizer CEO Bourla swears pure intentions in the rush to develop a Covid-19 vaccine. But will the public believe it?

5 years ago

Sean Bohen's break from biopharma is over. The ex-AstraZeneca CMO has retired his Big Pharma jersey and is now — happily — running a little biotech

5 years ago

Pharma's battered rep gets a modest facelift in the latest industry ratings from Gallup — but it's still looking pretty bad

5 years ago

CEOs join regulators and top scientists vowing to hold the line on Covid-19 vaccine. But will that get in the way of Trump's 'big surprise'?

5 years ago

Trump promises a safe, effective vaccine for Covid-19 before year’s end — 'or maybe even sooner!' So where does that leave the FDA?

5 years ago

FDA commish Hahn spotlights Oct 22 vaccine advisory meeting as the next big flashpoint in the Covid-19 campaign

5 years ago

The leaders in the race to develop a Covid-19 vaccine say they could have pivotal data in October — but Trump claims FDA is slowing recruitment

5 years ago

BioMarin CSO disses rivals for the hemophilia A gene therapy crown: Way behind, facing big recruitment challenges and at best a .6 on the gen-one scale

5 years ago

'October is coming,' and everyone still wants to know if a Covid-19 vaccine will be whisked through the FDA ahead of the election

5 years ago

First page Previous page 123 4 5 Next page Last page